s6y

Medicenna Therapeutics Corp.

Ticker
MDNAF
CIK
1807983
Industry
Pharmaceutical Preparations

Ownership 8

  1. SC 13G Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G/A Major Shareholders
  4. SC 13G/A Major Shareholders
  5. SC 13G/A Major Shareholders
  6. SC 13G Major Shareholders
  7. SC 13G/A Major Shareholders
  8. SC 13G Major Shareholders

Prospectus 2

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Other 168

  1. D Exempt (Private) Offering
  2. D Exempt (Private) Offering
  3. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  4. EFFECT Notice of Effectiveness
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. AW Withdrawal of amendment to a registration statement filed under the Securities Act

All 168 other filings